News & Updates

Interval between biopsy and RARP does not impact biochemical recurrence in prostate cancer
Interval between biopsy and RARP does not impact biochemical recurrence in prostate cancer
28 Dec 2021
Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer
Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer
05 Dec 2021
Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?
Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?
02 Dec 2021

Treatment with docetaxel appears beneficial in patients with low- and high-burden metastatic hormone-sensitive prostate cancer, a study has shown. However, no consistent differences for overall survival are seen in subgroup analyses as regards volume of metastatic disease.

Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?
02 Dec 2021